GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Provexis PLC (AQSE:PXS.GB) » Definitions » Cash Flow for Lease Financing

Provexis (AQSE:PXS.GB) Cash Flow for Lease Financing : £0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Provexis Cash Flow for Lease Financing?

Provexis's Cash Flow for Lease Financing for the six months ended in Sep. 2024 was £0.00 Mil. Provexis's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Sep. 2024 was £0.00 Mil.

Compared with last quarter (£0.00 Mil in Mar. 2024 ), Provexis's Cash Flow for Lease Financing remained the same in Sep. 2024 (£0.00 Mil).

Provexis Cash Flow for Lease Financing Historical Data

The historical data trend for Provexis's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Provexis Cash Flow for Lease Financing Chart

Provexis Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Provexis Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Provexis Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Provexis Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Provexis's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Provexis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Provexis PLC (AQSE:PXS.GB) » Definitions » Cash Flow for Lease Financing
Comparable Companies
AQSE:ANA LSE:N4P LSE:CEL LSE:STX LSE:EAH ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR
Traded in Other Exchanges
PXS:UK
Address
2 Blagrave Street, I Ford, Reading, Berkshire, GBR, RG1 1AZ
Website
https://www.provexis.com
Provexis PLC is a British food company. It is engaged in developing and licensing the Fruitflow, which is patented, natural, breakthrough ingredient which helps with platelet aggregation. Fruitflow reduces the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can result in heart attack and stroke. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.

Provexis Headlines

No Headlines